ATNM vs MRNA · rev $35.0M vs rev $145.0M
Actinium Pharmaceuticals Inc (ATNM) versus Moderna Inc (MRNA) — a side-by-side from cached financials, not a winner call.
Actinium Pharmaceuticals Inc (ATNM) is a biotechnology company listed on US.
Moderna Inc (MRNA) is a biotechnology company listed on NASDAQ. It is led by Stéphane Bancel M.B.A..
Latest reported ATNM revenue for 2026-06-30 was $35.0M. Net income was $22.4M. Revenue was up 38788.9% from 2025-09-30 to 2026-06-30. ATNM currently screens at market cap $33.9M.
Latest reported MRNA revenue for 2026-06-30 was $145.0M. Net income was -$782.0M. Revenue was down 62.7% from 2026-03-31 to 2026-06-30. MRNA currently screens at market cap $24.52B.
ATNM currently screens at market cap $33.9M. MRNA currently screens at market cap $24.52B.
Not investment advice. Open the ATNM and MRNA stock pages for the full models.
Not investment advice.